GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) » Definitions » Interest Expense

Henan Lingrui Pharmaceutical Co (SHSE:600285) Interest Expense : ¥2 Mil (TTM As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Henan Lingrui Pharmaceutical Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Henan Lingrui Pharmaceutical Co's interest expense for the three months ended in Mar. 2024 was ¥ -0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Henan Lingrui Pharmaceutical Co's Operating Income for the three months ended in Mar. 2024 was ¥ 207 Mil. Henan Lingrui Pharmaceutical Co's Interest Expense for the three months ended in Mar. 2024 was ¥ -0 Mil. Henan Lingrui Pharmaceutical Co's Interest Coverage for the quarter that ended in Mar. 2024 was 1,430.64. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Henan Lingrui Pharmaceutical Co Interest Expense Historical Data

The historical data trend for Henan Lingrui Pharmaceutical Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henan Lingrui Pharmaceutical Co Interest Expense Chart

Henan Lingrui Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.97 -1.10 -1.50 -0.78 0.18

Henan Lingrui Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.37 1.39 -0.26 1.41 -0.15

Henan Lingrui Pharmaceutical Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Henan Lingrui Pharmaceutical Co  (SHSE:600285) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Henan Lingrui Pharmaceutical Co's Interest Expense for the three months ended in Mar. 2024 was ¥-0 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥207 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ¥7 Mil.

Henan Lingrui Pharmaceutical Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2024 )/Interest Expense (Q: Mar. 2024 )
=-1*207.443/-0.145
=1,430.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Henan Lingrui Pharmaceutical Co (SHSE:600285) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) » Definitions » Interest Expense
Comparable Companies
SHSE:688276 SHSE:603456 SHSE:600572 SZSE:000766 SHSE:600420 SZSE:002399 SZSE:300558 SZSE:002332 SHSE:600993 SZSE:300705 XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
No. 59 Jiefang Chengguan Road, Xinxian, Xinyang, Henan, CHN, 465550
Website
http://www.lingrui.com
Henan Lingrui Pharmaceutical Co Ltd is a Chinese company engaged in the development, production, and distribution of pharmaceuticals. The Company's products include tablets, capsules, injections and other medicines.
Executives
Wu Xi Zhen Director
Li Jin Supervisors
Ye Qiang senior management
Chen Yan Directors, senior managers
Wu Hui Bin senior management
Yu Peng Director
Zhao Zhi Jun Director
Li Lei senior management
Feng Guo Xin Directors, senior managers
Pan Zi Run Director
Xiong Wei Zheng Director
Tang Wei Supervisors
Cheng Jian Jun Director
Zhang Jun Bing Director
Xia Hui senior management

Henan Lingrui Pharmaceutical Co (SHSE:600285) Headlines

No Headlines